Do you see any chance that if P3 holistically fails, the drug could still get approved for a more limited clinical approach, like PCV or occult? In footy terms, if P3 doesn’t kick a goal, could we at least get a point instead of being out of bounds on the full? What do you think?
Do you see any chance that if P3 holistically fails, the drug...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $670.9M | |||
| Open | High | Low | Value | Volume |
| 54.5¢ | 56.0¢ | 53.8¢ | $768.2K | 1.408M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 36501 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 99019 | 16 |
View Market Depth
| Last trade - 15.52pm 27/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |